Recognition memory decline is associated with the progression to prodromal Alzheimer's disease in asymptomatic at-risk individuals

J Neurol. 2024 Dec 16;272(1):70. doi: 10.1007/s00415-024-12834-y.

Abstract

Episodic memory (EM) alterations are a hallmark of Alzheimer's disease (AD). We assessed EM longitudinally in cognitively normal elders at-risk for AD (with subjective memory complaints), as a function of amyloid-β (Aβ) burden, neurodegeneration (N), and progression to prodromal AD. We stratified 264 INSIGHT-preAD study subjects in controls (Aβ-/N-), stable/N- or N + (Aβ +), and progressors/N- or N + (Aβ +) groups (progressors were included only until AD-diagnosis). We used linear mixed-effect models with Aβ and N status, or progression to AD as factors, to analyze behavioral performance in an old/new word-recognition task based on the free and cued selective reminding test (FCSRT). The controls and stable/N- groups showed near-ceiling accuracy and RT improvement across follow-up. The stable/N + group showed accuracy reduction and no RT improvement, i.e., Aβ + /N + cumulative effect. The progressors showed a marked performance decline. EM alterations may constitute early preclinical markers of progression to prodromal AD, while individuals are cognitively normal according to neuropsychological standards.

Keywords: Alzheimer’s disease (AD); Episodic memory; Free and cued selective reminding test (FCSRT); Neurodegeneration; Old/new effect; β-amyloid.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Alzheimer Disease* / diagnosis
  • Alzheimer Disease* / physiopathology
  • Amyloid beta-Peptides* / cerebrospinal fluid
  • Asymptomatic Diseases
  • Disease Progression*
  • Female
  • Humans
  • Longitudinal Studies
  • Male
  • Memory Disorders* / diagnosis
  • Memory Disorders* / etiology
  • Memory Disorders* / physiopathology
  • Memory, Episodic
  • Neuropsychological Tests
  • Prodromal Symptoms*
  • Recognition, Psychology* / physiology

Substances

  • Amyloid beta-Peptides